| abstract |
The present invention relates to a compound belonging to the family of fluorinated pyridazin-3-ones, for its use in the treatment of bronchopulmonary affections, said compound having the formula (I): or a pharmaceutically acceptable salt of said compound, formula (I wherein: R1 is H, alkyl, aryl or heteroaryl; either R2 and R3 represent, independently of one another, H, alkyl, aryl or heteroaryl, or R2 and R3 are bridged within the same ring or through a plurality of rings; RF represents CF3, (CF2) nCF3 or CF2H with n being an integer from 1 to 7. |